231 related articles for article (PubMed ID: 12714825)
1. Mixed myelodysplastic syndrome and myeloproliferative disorder with bone marrow and pulmonary fibrosis: the role of megakaryocytes.
Rosenstingl S; Brouland JP; Zini JM; Tobelem G; Dupuy E
Acta Haematol; 2003; 109(3):145-9. PubMed ID: 12714825
[TBL] [Abstract][Full Text] [Related]
2. Severe case of peripheral leukocytosis initially diagnosed as myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, but possibly prefibrotic primary myelofibrosis.
Ota S; Hiramatsu Y; Kondo E; Kasahara A; Takada S; Umena S; Noguchi T; Tanimoto M; Matsumura T
Acta Med Okayama; 2014 Dec; 68(6):363-8. PubMed ID: 25519030
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
[TBL] [Abstract][Full Text] [Related]
4. Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases.
Pagliuca A; Layton DM; Manoharan A; Gordon S; Green PJ; Mufti GJ
Br J Haematol; 1989 Apr; 71(4):499-504. PubMed ID: 2640542
[TBL] [Abstract][Full Text] [Related]
5. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
Wilkins BS
Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
[No Abstract] [Full Text] [Related]
6. Acute myelofibrosis.
Rupani M
Am J Clin Pathol; 1982 Apr; 77(4):475-8. PubMed ID: 6951405
[TBL] [Abstract][Full Text] [Related]
7. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
8. Megakaryocytes and myelofibrosis in gray platelet syndrome.
Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
[TBL] [Abstract][Full Text] [Related]
9. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
Ohshima K; Kikuchi M; Takeshita M
J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
[TBL] [Abstract][Full Text] [Related]
10. Myelofibrosis in cats with myelodysplastic syndrome and acute myelogenous leukemia.
Blue JT
Vet Pathol; 1988 Mar; 25(2):154-60. PubMed ID: 2834859
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
Zankovich R; Thiele J; Fischer R; Diehl V
Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
[No Abstract] [Full Text] [Related]
12. The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis.
Kremer M; Horn T; Dechow T; Tzankov A; Quintanilla-Martínez L; Fend F
Leukemia; 2006 Jul; 20(7):1315-6. PubMed ID: 16617316
[No Abstract] [Full Text] [Related]
13. Reply to Kremer M et al., the JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis.
Ohyashiki K; Ohyashiki JH
Leukemia; 2006 Jul; 20(7):1297-8. PubMed ID: 16617315
[No Abstract] [Full Text] [Related]
14. Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features.
Verhoef GE; De Wolf-Peeters C; Ferrant A; Deprez S; Meeus P; Stul M; Zacheé P; Cassiman JJ; Van den Berghe H; Boogaerts MA
Ann Hematol; 1991 Nov; 63(5):235-41. PubMed ID: 1958747
[TBL] [Abstract][Full Text] [Related]
15. Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.
Santana-Davila R; Tefferi A; Holtan SG; Ketterling RP; Dewald GW; Knudson RA; Steensma DP; Chen D; Hoyer JD; Hanson CA
Leuk Res; 2008 Dec; 32(12):1927-30. PubMed ID: 18538839
[TBL] [Abstract][Full Text] [Related]
16. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
17. Thrombocytosis with sideroblastic erythropoiesis: a mixed myeloproliferative myelodysplastic syndrome.
Gupta R; Abdalla SH; Bain BJ
Leuk Lymphoma; 1999 Aug; 34(5-6):615-9. PubMed ID: 10492088
[TBL] [Abstract][Full Text] [Related]
18. Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.
Gleitz HFE; Dugourd AJF; Leimkühler NB; Snoeren IAM; Fuchs SNR; Menzel S; Ziegler S; Kröger N; Triviai I; Büsche G; Kreipe H; Banjanin B; Pritchard JE; Hoogenboezem R; Bindels EM; Schumacher N; Rose-John S; Elf S; Saez-Rodriguez J; Kramann R; Schneider RK
Blood; 2020 Oct; 136(18):2051-2064. PubMed ID: 32726410
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary fibrosis with megakaryocyte infiltration in agnogenic myeloid metaplasia with thrombocytosis.
Yamauchi K; Shimamura K
Eur J Haematol; 1996 Oct; 57(4):325-7. PubMed ID: 8982297
[No Abstract] [Full Text] [Related]
20. Myelodysplastic syndrome with myelofibrosis: myelodysplastic syndrome as a major primary disorder for acute myelofibrosis.
Takahashi M; Koike T; Nagayama R; Fujiwara M; Koyama S; Ohnishi M; Nakamori Y; Soga N; Aoki S; Tatewaki W
Clin Lab Haematol; 1991; 13(1):17-23. PubMed ID: 2060260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
